COMPARATIVE EVALUATION OF ANTIDEPRESSANT EFFECTS OF MINOCYCLINE AND FLUOXETINE IN MALE WISTAR RATS.
Main Article Content
Keywords
Depression, Minocycline, neuroinflammation, forced swim test, Fluoxetine.
Abstract
Background: Selective serotonin reuptake inhibitors (SSRIs) are the most prescribed drugs for the treatment of Major Depressive Disorders (MDD). But many patients do not respond adequately to conventional antidepressant therapy. Hence there is a continued need for development of novel efficacious depression interventions. Minocycline has a pronounced inhibitory effect on the brain’s microglia, and can beneficially target the pathophysiology of depression. Inflammation is strongly associated with depression and pro-inflammatory medications carry the potential to induce depressive symptoms in humans. Microglia are the primary immune cells that mediate neuroinflammation and minocycline is capable of reducing inflammation by directly suppressing microglia activation and by indirectly inhibiting microglia-induced inflammatory processes. Keeping this in mind the present study was done to compare the antidepressant effects of minocycline with fluoxetine in male wistar rats.
Methods: 18 Male Wistar Rats, aged 8-10 months, each weighing 150-200 gm were included in the study. Each animal was subjected to chronic mild stressors for 14 days to create depression. After 14 days, the rats underwent behavioral tests like immobility by Forced swim test and Open field tests and were tested for Sucrose preference tests. The rats were divided randomly into 5 groups with each group having 6 animals. Group I (Minocycline 25mg/kg/day), Group II (Minocycline 50mg/kg/day), Group III (Minocycline100mg/kg/day), Fluoxetine(30mg/kg/day) and group V rats were given RO water once daily via oral route for a period of 28 days.After 28 days, the animals were again subjected to forced swim test, open field tests and sucrose preference tests. Intergroup and intragroup comparison using ANOVA and t tests was done. p value<0.05 was considered significant.
Results: The study showed significant antidepressant-like effects in Groups II, III, and IV in swim Despair Test post drug treatment. There were no significant locomotor changes in any group in open field test. Improvement in anhedonia-like behavior in Groups I, II, and IV using Sucrose Preference Test was significant.
Conclusion: The present study revealed that minocycline showed antidepressant like effects at different doses which can be further explored using larger sample size.
References
2. Ciulla L, Menezes HS, Bueno BB, Schuh A, Alves RJ, Abegg MP. Antidepressant behavioral effects of duloxetine and fluoxetine in the rat forced swimming test. Acta Cir Bras. 2007 Sep-Oct;22(5):351-4. doi: 10.1590/s0102-86502007000500005. PMID: 17923954
3. Zavvari F, Nahavandi A, Goudarzi M. Fluoxetine attenuates stress-induced depressive-like behavior through modulation of hippocampal GAP43 and neurogenesis in male rats. J Chem Neuroanat. 2020 Jan;103:101711. doi: 10.1016/j.jchemneu.2019.101711. Epub 2019 Nov 6. PMID: 31705954
4. Amani M, Shokouhi G, Salari AA. Minocycline prevents the development of depression-like behavior and hippocampal inflammation in a rat model of Alzheimer's disease. Psychopharmacology (Berl). 2019 Apr;236(4):1281-1292. doi: 10.1007/s00213-018-5137-8. Epub 2018 Dec 4. PMID: 30515523
5. Reis, D.J., Casteen, E.J. & Ilardi, S.S. The antidepressant impact of minocycline in rodents: A systematic review and meta-analysis. Sci Rep 9, 261 (2019). https://doi.org/10.1038/s41598-018-36507-9
6. Mao, Q.Q.; Xian, Y.F.; Ip, S.P.; Tsai, S.H.; Che, C.T. Long-term treatment with peony glycosides reverses chronic unpredictable mild stress-induced depressive-like behavior via increasing expression of neurotrophins in rat brain. Behav. Brain Res. 2010, 210, 171–177. [CrossRef]
7. Detanico, B.C.; Piato, A.L.; Freitas, J.J.; Lhullier, F.L.; Hidalgo, M.P.; Caumo, W.; Elisabetsky, E. Antidepressant-like effects of melatonin in the mouse chronic mild stress model. Eur. J. Pharmacol. 2009, 607, 121–125.
8. Mitchell, P.J.; Redfern, P.H. Animal models of depressive illness: The importance of chronic drug treatment. Curr. Pharm. Des. 2005, 11, 171–203. [CrossRef]
9. Katz, R.J. Animal model of depression: Pharmacological sensitivity of a hedonic deficit. Pharmacol. Biochem. Behav.1982, 16, 965–968. [CrossRef]
10. Porsolt, R.D.; Le Pichon, M.; Jalfre, M. Depression: A new animal model sensitive to antidepressant treatments. Nature 1977, 266, 730–732. [CrossRef] [PubMed]
11. Borsini, F. and Meli, A. (1988) Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology (Berl.) 94, 147–16
12. URL: http://www.jove.com/video/52587, DOI: doi:10.3791/52587
13. Petit-Demouliere, B.; Chenu, F.; Bourin, M. Forced swimming test in mice: A review of antidepressant activity. Psychopharmacology (Berl.) 2005, 177, 245–255. [CrossRef] [PubMed]
14. Lucki, I. (1997) The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav. Pharmacol. 8, 523–532
15. Katz, R.J.; Roth, K.A.; Carroll, B.J. Acute and chronic stress e_ects on open field activity in the rat: Implications for a model of depression. Neurosci. Biobehav. Rev. 1981, 5, 247–251. [CrossRef]
16. Wang W, Wang R, Xu J, Qin X, Jiang H, Khalid A, Liu D, Pan F, Ho CSH and Ho RCM (2018) Minocycline Attenuates Stress-Induced Behavioral Changes via Its Anti-inflammatory Effects in an Animal Model of Post-traumatic Stress Disorder. Front. Psychiatry 9:558. doi: 10.3389/fpsyt.2018.00558
17. Willner, P.; Towell, A.; Sampson, D.; Sophokleous, S.; Muscat, R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl.) 1987, 93, 358–364. [CrossRef]
18. Slattery, D. A. & Cryan, J. F. Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat. Protoc. 7, 1009–1014, https://doi.org/10.1038/nprot.2012.044 (2012).
19. Mesripour, Azadeh; Kavianpour, Mohsen; and Hajhashemi, Valiollah “Antidepressant-like effect of minocycline in mice forced swimming test: minor involvement of the noradrenergic system," The Thai Journal of Pharmaceutical Sciences. 2025,( 43:3) DOI: https://doi.org/10.56808/3027-7922.3043
20. Krishnan, V. & Nestler, E. J. Animal models of depression: molecular perspectives. Curr. Top. Behav. Neurosci. (2011) 7, 121–147, https://doi.org/10.1007/7854_2010_108
21. Cryan JF, Markou A, Lucki I. Assessing antidepressant activity in rodents: Recent developments and future needs. Trends Pharmacol Sci 2002;23:238-45.
22. W. Xue, P. Wang, B. Li, Y. Li, X. Xu, F. Yang, X. Yao, Y.Z. Chen, F. Xu, F. Zhu, Identification of the inhibitory mechanism of FDA approved selective serotonin reuptake inhibitors: an insight from molecular dynamics simulation study, Phys. Chem. Chem. Phys. 18 (4) (2016) 3260–3271.
23. J.P. Feighner, Mechanism of action of antidepressant medications, J. Clin. Psychiatry 60 (Suppl 4) (1999) 4–11, discussion 12-13.
24. Garrido-Mesa N, Zarzuelo A, Gálvez J. Minocycline: far beyond an antibiotic. Br J Pharmacol. (2013) 169:337–52. doi: 10.1111/bph.12139 21.
25. 25. Dean OM, Datafranco J, Giorlando F, Berk M. Minocycline: therapeutic potential in psychiatry. Cns Drugs (2012) 26:391. doi: 10.2165/11632000-000000000-00000
26. 26. Tikka T, Fiebich BL, Goldsteins G, Keinänen R, Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci. (2001) 21:2580–8. doi: 10.1523/JNEUROSCI.21-08-02580.2001
27. 27. Kobayashi K, Imagama S, Ohgomori T, Hirano K, Uchimura K, Sakamoto K, et al. Minocycline selectively inhibits M1 polarization of microglia. Cell Death Dis. (2013) 4:e525. doi: 10.1038/cddis. 2013.54.

